Discovery of [HMPL-504] as a Highly Potent and Selective Mesenchymal-Epithelial Transition Factor (c-Met) Inhibitor in Clinical Development for Treatment of Cancer (Journal of Medicinal Chemistry 2014)

For detailed information, please visit:

http://pubs.acs.org/doi/abs/10.1021/jm500510f